Literature DB >> 8609162

Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments.

P A Warmerdam1, E O Long, P A Roche.   

Abstract

Newly synthesized class II molecules of the major histocompatibility complex must be transported to endosomal compartments where antigens are processed for presentation to class II-restricted T cells. The invariant chain (Ii), which assembles with newly synthesized class II alpha- and beta-chains in the endoplasmic reticulum, carries one or more targeting signals for transport to endosomal compartments where Ii dissociates from alpha beta Ii complexes. Here we show that the transport route of alpha beta Ii complexes is regulated selectively by two forms of Ii (p33 and p35) that are generated by the use of alternative translation initiation sites. Using a novel quantitative surface arrival assay based on labeling with [6-3H]-D-galactose combined with biochemical modification at the cell surface with neuraminidase, we demonstrate that newly synthesized alpha beta Ii molecules containing the Ii-p33 isoform can be detected on the cell surface shortly after passage through the Golgi apparatus/trans-Golgi network. A substantial amount of these alpha beta Ii complexes are targeted to early endosomes either directly from the trans-Golgi network or after internalization from the cell surface before their delivery to antigen processing compartments. The fraction of alpha beta Ii complexes containing the p35 isoform of Ii with a longer cytosolic domain was not detected at the cell surface as determined by iodination of intact cells and the lack of susceptibility to neuraminidase trimming on ice. However, treatment with neuraminidase at 37 degrees C did reveal that some of the alpha beta Ii-p35 complexes traversed early endosomes. These results demonstrate that a fraction of newly synthesized class II molecules arrive at the cell surface as alpha beta Ii complexes before delivery to antigen processing compartments and that class II alpha beta Ii complexes associated with the two isoforms of Ii are sorted to these compartments by different transport routes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609162      PMCID: PMC2120797          DOI: 10.1083/jcb.133.2.281

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  52 in total

1.  Functional and ultrastructural evidence for intracellular formation of major histocompatibility complex class II-peptide complexes during antigen processing.

Authors:  C V Harding; E R Unanue; J W Slot; A L Schwartz; H J Geuze
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

2.  Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding.

Authors:  P A Roche; P Cresswell
Journal:  Nature       Date:  1990-06-14       Impact factor: 49.962

Review 3.  The biogenesis of lysosomes.

Authors:  S Kornfeld; I Mellman
Journal:  Annu Rev Cell Biol       Date:  1989

4.  Two forms of the Ia antigen-associated invariant chain result from alternative initiations at two in-phase AUGs.

Authors:  M Strubin; E O Long; B Mach
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

5.  Role for intracellular proteases in the processing and transport of class II HLA antigens.

Authors:  J S Blum; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

6.  The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route.

Authors:  J J Neefjes; V Stollorz; P J Peters; H J Geuze; H L Ploegh
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

7.  Monensin prevents terminal glycosylation of the N- and O-linked oligosaccharides of the HLA-DR-associated invariant chain and inhibits its dissociation from the alpha-beta chain complex.

Authors:  C E Machamer; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

8.  Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment.

Authors:  C G Odorizzi; I S Trowbridge; L Xue; C R Hopkins; C D Davis; J F Collawn
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

9.  Intracellular movement of two mannose 6-phosphate receptors: return to the Golgi apparatus.

Authors:  J R Duncan; S Kornfeld
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

10.  Structural requirements for pairing of alpha and beta chains in HLA-DR and HLA-DP molecules.

Authors:  D R Karp; C L Teletski; D Jaraquemada; W L Maloy; J E Coligan; E O Long
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

View more
  16 in total

1.  Early endosomes are required for major histocompatiblity complex class II transport to peptide-loading compartments.

Authors:  V Brachet; G Péhau-Arnaudet; C Desaymard; G Raposo; S Amigorena
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

2.  Surface-expressed invariant chain (CD74) is required for internalization of human leucocyte antigen-DR molecules to early endosomal compartments.

Authors:  G Moldenhauer; C Henne; J Karhausen; P Möller
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

3.  The chondroitin sulfate form of invariant chain trimerizes with conventional invariant chain and these complexes are rapidly transported from the trans-Golgi network to the cell surface.

Authors:  Lynne S Arneson; Jim Miller
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

Review 4.  MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.

Authors:  Toine ten Broeke; Richard Wubbolts; Willem Stoorvogel
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

5.  Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation.

Authors:  T Kuwana; P A Peterson; L Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

Review 6.  The biological function and significance of CD74 in immune diseases.

Authors:  Huiting Su; Ning Na; Xiaodong Zhang; Yong Zhao
Journal:  Inflamm Res       Date:  2016-10-17       Impact factor: 4.575

7.  Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass.

Authors:  Se Hwan Mun; Hee Yeon Won; Paula Hernandez; Hector Leonardo Aguila; Sun-Kyeong Lee
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

Review 8.  CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract.

Authors:  Ellen J Beswick; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

9.  Cell surface major histocompatibility complex class II proteins are regulated by the products of the gamma(1)34.5 and U(L)41 genes of herpes simplex virus 1.

Authors:  Joanne Trgovcich; David Johnson; Bernard Roizman
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection.

Authors:  C Jenkins; W Garcia; M J Godwin; J V Spencer; J Lewis Stern; A Abendroth; B Slobedman
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.